E
ECO Animal Health Group PLC
LSE:EAH
ECO Animal Health Group PLC
LSE:EAH
Price:
103.5
GBX
5.08%
Market Cap:
£70.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
ECO Animal Health Group PLC
LSE:EAH
|
UK |
|
Dongwha Pharm Co Ltd
KRX:000020
|
KR |
|
T
|
Tai United Holdings Ltd
HKEX:718
|
HK |
|
American Energy Partners Inc
OTC:AEPT
|
US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
|
Pivotree Inc
XTSX:PVT
|
CA |
|
U
|
UTI Inc
KOSDAQ:179900
|
KR |
|
Golden Wheel Tiandi Holdings Company Ltd
HKEX:1232
|
CN |
|
S
|
Solborn Inc
KOSDAQ:035610
|
KR |
|
Intexa SA
PAR:ITXT
|
FR |
|
A
|
AcelRx Pharmaceuticals Inc
F:R5X
|
US |
|
10X Genomics Inc
NASDAQ:TXG
|
US |
|
World Financial Holding Group
OTC:WFHG
|
US |
|
Asahi Printing Co Ltd
TSE:3951
|
JP |
|
D
|
Duty Free International Ltd
SGX:5SO
|
SG |
Multiples-Based Value
The Multiples-Based Value for ECO Animal Health Group PLC (EAH) under the Base Case is hidden GBX. Compared with the current market price of 103.5 GBX, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EAH Multiples-Based Value
LOCKED
Multiples Across Competitors
EAH Competitors Multiples
ECO Animal Health Group PLC Competitors
ECO Animal Health Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
E
|
ECO Animal Health Group PLC
LSE:EAH
|
70.1m GBP | 0.8 | 23.2 | 5.8 | 8.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD | 13.1 | 41.4 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.7B USD | 6 | 27.3 | 17.5 | 22.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP | 5.1 | 29.6 | 16.4 | 23 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF | 5 | 20.2 | 12.5 | 16.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.8 | 11.4 | 8.4 | 9.8 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR | 2.7 | 15.2 | 8.2 | 10.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
